封面
市场调查报告书
商品编码
1514185

全球高内涵筛检(HCS) 市场

High Content Screening (HCS)

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年,全球高内涵筛检(HCS) 市场预计将达到 22 亿美元

全球高内涵筛检(HCS) 市场预计 2023 年为 12 亿美元,预计到 2030 年将达到 22 亿美元,2023-2030 年分析期间复合年增长率为 9.1%。 HCS 设备是本报告分析的细分市场之一,预计复合年增长率为 9.3%,到分析期结束时将达到 10 亿美元。分析期内,HCS 消耗品领域的复合年增长率预计为 8.2%。

美国市场预估为3.097亿美元,中国预期复合年增长率为12.2%

预计 2023 年美国高内涵筛检(HCS) 市场规模将达 3.097 亿美元。中国作为全球第二大经济体,预计2030年市场规模将达到4.927亿美元,2023-2030年分析期间复合年增长率为12.2%。其他值得注意的区域市场包括日本和加拿大,在分析期间预计复合年增长率分别为 6.0% 和 7.2%。在欧洲,德国的复合年增长率预计约为 7.0%。

全球高内涵筛检(HCS) 市场 – 主要趋势与驱动因素总结

高内涵筛检(HCS) 透过即时详细观察细胞过程,正在彻底改变生物研究和药物发现领域,特别是促进个人化医疗的发展。 HCS 利用先进的成像和分析技术来研究各种化合物对细胞的影响,提供远远超出使用分离细胞的传统方法的见解。这项技术变得越来越重要,特别是其在活体多细胞结构(例如类器官和组织切片)中的应用。这种细胞层面的微妙观察使我们能够更好地了解表征健康和疾病状态的细胞动力学,从而突破生物医学研究和治疗开发的界限。

在癌症研究领域,HCS 的效用已得到证实。在人工环境中培养癌细胞的传统模型可能会导致不自然的行为,但 HCS 透过使用含有细胞外基质的环境解决了这个问题,从而更自然地引发细胞行为和反应。该设置允许创建紧密模仿自然肿瘤环境的微组织,并使用自动显微镜和先进的图像分析对各种药物进行测试。这种表型筛检透过识别肿瘤内的单一细胞如何响应特定药物并揭示抗药性和疗效的变化来帮助个人化治疗。这种治疗方法显着增加了我们对癌细胞动力学的理解,有助于建立更有效和个人化的治疗方法,并最大限度地减少与癌症治疗相关的试验。

然而,HCS 的临床整合面临重大挑战,这主要是由于维护准确的3D培养和分析它们产生的大型资料集所涉及的复杂性。儘管存在这些障碍,技术进步正在促进适合高通量筛检的组织样结构的小型化,并提高 HCS 应用的可扩展性。 HCS 的主要成长动力包括与多细胞和 3D 模型的整合、成像技术的进步以及自动分析软体的开发。此外,随着对个人化医疗的日益重视和药物发现工作的不断扩大,需要更有效的筛检技术,例如 HCS。此外,监管部门对预测模型的支持以及消费者对更快、更准确测试方法的需求也极大地促进了HCS 在药物开发和个人化医疗领域的广泛采用和持续发展,这证实了HCS 在药物开发和个人化医疗领域日益增长的影响力。

受访企业范例(21家知名企业)

  • BD Biosciences
  • BioTek Instruments Inc.
  • EMD Millipore
  • Essen BioScience
  • Evotec AG
  • GE Healthcare Life Sciences
  • Genedata AG
  • IntelliCyt Corporation
  • Molecular Devices Inc.
  • PerkinElmer Inc.
  • Thermo Fischer Scientific Inc.
  • TTP LabTech Ltd.
  • Yokogawa Electric Corporation

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP-6754

Global High Content Screening (HCS) Market to Reach US$2.2 Billion by 2030

The global market for High Content Screening (HCS) estimated at US$1.2 Billion in the year 2023, is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 9.1% over the analysis period 2023-2030. HCS Instruments, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$1.0 Billion by the end of the analysis period. Growth in the HCS Consumables segment is estimated at 8.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$309.7 Million While China is Forecast to Grow at 12.2% CAGR

The High Content Screening (HCS) market in the U.S. is estimated at US$309.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$492.7 Million by the year 2030 trailing a CAGR of 12.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.0% and 7.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.0% CAGR.

Global High Content Screening (HCS) Market - Key Trends and Drivers Summarized

High Content Screening (HCS) is revolutionizing the field of biological research and drug discovery by enabling detailed observations of cellular processes in real-time, particularly enhancing the development of personalized medicine. HCS utilizes advanced imaging and analysis techniques to study the effects of various compounds on cells, offering insights far beyond traditional methodologies that used isolated cells. This technique is becoming increasingly pivotal, especially with its application in living multicellular structures like organoids or tissue sections, which more accurately simulate biological interactions within organisms. This nuanced observation at the cellular level allows for a deeper understanding of the cellular dynamics that characterize health and disease states, pushing forward the boundaries of biomedical research and therapeutic development.

In the realm of cancer research, HCS has proven invaluable. Traditional models that cultivate tumor cells in artificial environments can induce unnatural behaviors; however, HCS addresses this by using environments that include an extracellular matrix, leading to more natural cellular behavior and responses. This setup allows for the creation of microtissues that closely mimic natural tumor environments, which are then tested against various drugs using automated microscopy and sophisticated image analysis. This phenotypic screening helps to personalize treatment by identifying how individual cells within a tumor respond to specific drugs, highlighting the variability in drug resistance and efficacy. This method significantly refines our understanding of cancer cell dynamics and is instrumental in crafting more effective and personalized treatment regimens, thus minimizing the trial-and-error often associated with cancer therapies.

The integration of HCS into clinical practice, however, faces significant challenges, primarily due to the complexities involved in maintaining accurate 3D cultures and the analysis of large datasets they generate. Despite these hurdles, technological advancements are facilitating the miniaturization of tissue-like structures suitable for high-throughput screening, enhancing the scalability of HCS applications. Key growth drivers for HCS include the integration with multicellular and 3D models, advancements in imaging technologies, and the development of automated analysis software. Additionally, the increasing emphasis on personalized medicine and the expansion of drug discovery efforts demand more effective screening technologies like HCS. Regulatory support for predictive models and consumer demand for quicker, more accurate testing methods also significantly contribute to the broader adoption and ongoing development of HCS, underscoring its growing impact on the fields of drug development and personalized medicine.

Select Competitors (Total 21 Featured) -

  • BD Biosciences
  • BioTek Instruments Inc.
  • EMD Millipore
  • Essen BioScience
  • Evotec AG
  • GE Healthcare Life Sciences
  • Genedata AG
  • IntelliCyt Corporation
  • Molecular Devices Inc.
  • PerkinElmer Inc.
  • Thermo Fischer Scientific Inc.
  • TTP LabTech Ltd.
  • Yokogawa Electric Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • High Content Screening (HCS) - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Drug Discovery and Development Propels Growth in HCS Market
    • Advances in Imaging Technologies Strengthen Business Case for High Content Screening Adoption
    • Increasing Focus on Personalized Medicine Expands Addressable Market Opportunity for HCS
    • Technological Innovations in Cell-Based Assays Drive Market Growth
    • Growing Use of HCS in Genomics and Proteomics Accelerates Market Penetration
    • Integration of AI and Machine Learning in HCS Throws the Spotlight on Enhanced Data Analysis and Prediction
    • Rising Investment in Biotechnology and Life Sciences Expands Market Scope for HCS Solutions
    • Advances in Miniaturization and Microfluidics Propel Development of High-Performance HCS Systems
    • Focus on Reducing Drug Development Costs and Time-to-Market Spurt Demand for HCS Technologies
    • Increasing Adoption of HCS in Academic and Research Institutions
    • Development of Novel 3D Cell Cultures Expands Addressable Market Opportunity for HCS
    • Advances in Fluorescence and High-Resolution Imaging Propel Growth in Precision Screening Applications
    • Rising Demand for Toxicology Testing and Safety Assessment Drives Adoption of HCS
    • Increasing Use of HCS in Stem Cell Research and Regenerative Medicine Expands Market Reach
    • Development of User-Friendly and Scalable HCS Platforms Fuels Market Adoption
    • Rising Importance of Target-Based and Phenotypic Screening Strengthens Business Case for HCS
    • Growing Adoption of HCS in Cancer Research and Immuno-Oncology Expands Market Scope
    • Focus on Enhancing Screening Efficiency and Throughput Drives Market Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World High Content Screening (HCS) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for High Content Screening (HCS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for High Content Screening (HCS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for High Content Screening (HCS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • High Content Screening (HCS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: Canada 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • JAPAN
    • High Content Screening (HCS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: Japan 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • CHINA
    • High Content Screening (HCS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: China Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: China 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • EUROPE
    • High Content Screening (HCS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for High Content Screening (HCS) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for High Content Screening (HCS) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for High Content Screening (HCS) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • FRANCE
    • High Content Screening (HCS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: France Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: France 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • GERMANY
    • High Content Screening (HCS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Germany 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Italy 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • High Content Screening (HCS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: UK 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 47: Spain Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Spain Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Spain 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 50: Russia Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Russia Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Russia 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Rest of Europe 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • High Content Screening (HCS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for High Content Screening (HCS) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for High Content Screening (HCS) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for High Content Screening (HCS) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Asia-Pacific 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • High Content Screening (HCS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 62: Australia Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Australia Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Australia 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • INDIA
    • High Content Screening (HCS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 65: India Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: India Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: India 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 68: South Korea Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: South Korea Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: South Korea 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 71: Rest of Asia-Pacific Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Rest of Asia-Pacific Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Rest of Asia-Pacific 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • High Content Screening (HCS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for High Content Screening (HCS) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for High Content Screening (HCS) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for High Content Screening (HCS) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Latin America 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 80: Argentina Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Argentina Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Argentina 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 83: Brazil Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Brazil Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Brazil 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 86: Mexico Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Mexico Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Mexico 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 89: Rest of Latin America Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Latin America Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Latin America 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • High Content Screening (HCS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for High Content Screening (HCS) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for High Content Screening (HCS) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for High Content Screening (HCS) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Middle East 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 98: Iran Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Iran Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Iran 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 101: Israel Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Israel Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Israel 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 104: Saudi Arabia Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Saudi Arabia Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Saudi Arabia 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 107: UAE Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UAE Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: UAE 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 110: Rest of Middle East Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of Middle East Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of Middle East 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030
  • AFRICA
    • High Content Screening (HCS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 113: Africa Recent Past, Current & Future Analysis for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Africa Historic Review for High Content Screening (HCS) by Product - Instruments, Consumables, Software and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Africa 16-Year Perspective for High Content Screening (HCS) by Product - Percentage Breakdown of Value Sales for Instruments, Consumables, Software and Other Products for the Years 2014, 2024 & 2030

IV. COMPETITION